MSB 2.91% $1.06 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-645

  1. 3,944 Posts.
    lightbulb Created with Sketch. 1350
    So as we all can see, shorts have been on the rise. To lend shares to the shorters has been a easy way for the larger holders to make a return. This has been said to be safe, but is it ?...

    I see that one particular firm that is well known for shorting is not as safe as one may think. A call could see some big moves in the coming days.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.06
Change
0.030(2.91%)
Mkt cap ! $1.210B
Open High Low Value Volume
$1.05 $1.09 $1.03 $5.796M 5.430M

Buyers (Bids)

No. Vol. Price($)
2 15990 $1.06
 

Sellers (Offers)

Price($) Vol. No.
$1.08 48632 3
View Market Depth
Last trade - 16.10pm 02/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.